Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants
about
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchisepticaMolecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulationSerum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussisRole of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulenceIdentification, characterization, and variation in expression of two serologically distinct O-antigen epitopes in lipopolysaccharides of Campylobacter fetus serotype A strains.Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic.Role of Bordetella O antigen in respiratory tract infection.Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cellsExpression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis.Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of Haemophilus influenzae type b.A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression.Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharideStructural characterization of the lipid A of Bordetella pertussis 1414 endotoxin.Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features.Structure of the terminal reducing heptasaccharide of polysaccharide 1 isolated from the Bordetella pertussis endotoxin.Isolation and characterization of the cytoplasmic and outer membranes of the Legionnaires' disease bacterium (Legionella pneumophila).Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis.Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzaeHeat-modifiable envelope proteins of Bordetella pertussis.Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b.Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulenceExpression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1.Pathophysiology of Campylobacter enteritis.Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli.Isolation and characterization of Bordetella pertussis phenotype variants capable of growing on nutrient agar: comparison with phases III and IV.Phenotypic variation and modulation in Bordetella bronchiseptica.Production and characterization of monoclonal antibodies directed against Bordetella pertussis lipopolysaccharide.Comparisons of Pasteurella multocida lipopolysaccharides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to determine relationship between group B and E hemorrhagic septicemia strains and serologically related group A strains.Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity.Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activitiesToward a new vaccine for pertussisPertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide.The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.Phenotypic phase variation in Haemophilus somnus lipooligosaccharide during bovine pneumonia and after in vitro passage.Siderophore production and membrane alterations by Bordetella pertussis in response to iron starvation.Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni.
P2860
Q21131623-F14098F4-4BDF-4AFA-8F79-B4321D1027D2Q24522458-B40CCC14-3C0B-4F44-9E2E-BBC6900BDA86Q30451113-B58E0308-399D-4441-9C70-84D4FD036D2FQ33999534-05358045-8158-450E-8C12-72A2434A2DBEQ34007840-4D483624-576D-417C-A246-DB4033FC750DQ34009776-CB956E41-8A84-4180-A45D-790A11D3D43BQ34094342-ACF62800-E5B5-4C87-AEBE-60E240D5081CQ34531338-B8250549-D084-4065-A528-EC997C6D61C2Q34889754-C2DBD3C7-D91C-451F-9981-BF98E155FD55Q35073933-864E4C77-D17E-4EB9-881F-AB6FEC530B62Q35111039-A3EC665F-BC41-440D-BDE4-BC39D44C675AQ35584100-21FC3F88-ED5F-4C23-AAFB-B336BC0B9494Q35774055-D4D0C8CE-2488-4D97-8AD4-FCBE5AD0D6DBQ35968686-C12C9419-D7DF-47DF-BA88-1FC5912F8597Q36158597-67418268-6FC7-44A6-B979-1DF91F333EFFQ36302603-7D02DA78-F8E6-430E-87E2-1051AA32FF98Q36349818-A6DB5921-8CE0-401B-93D0-AD97D4229CB0Q36947250-F89BADBF-2F1E-4F2F-943A-247A6FC6F62EQ36973187-9DF718BD-2FA7-47F6-8E2F-A4DF8495DCE7Q37008657-471AF35E-3550-47AD-BAC4-733A26C34A1FQ37012011-BB203E94-3B30-43C1-A822-1BD62A19E968Q37016943-D37E6D89-861C-4CFE-8E4A-5554A4F1D312Q37030278-E24EFF55-156A-4C5E-A3E2-39647161E603Q37041731-905AB781-3A25-474F-B24D-D1AAA33FE673Q37062418-7AE5E297-42B5-4BCA-9BC0-45DD65DE1665Q37077709-FB016B59-87BA-4947-8EC4-0ED125797AFFQ37080045-87D4B208-9637-47D1-A0DA-70381628B5F0Q37085558-B7274A8D-C0B1-4075-80B6-FDB46E27E6E2Q37143247-61C78A88-E7BC-43D2-AC6C-595447B63F07Q37181041-47631618-C936-4F45-8FB8-07040AE57EB9Q37256450-0690EA9E-3DA4-48B4-9B4D-66C3278A266CQ37623676-960C6D0C-0D52-4873-A2DF-EA9CF57BEAECQ37628007-B14ADCCD-35E3-434F-A700-5C86C8885F66Q39522998-E861F7A9-A654-4121-90F1-DB913EC8FADAQ39564014-38477047-5BCE-42E6-8A90-457D5C5EBF9BQ39573830-0927CE6A-F076-455E-AF6B-78A1D4859D4EQ40147335-76021832-9C46-466D-A485-23E1BDFC7440Q40148529-0EC08799-B40B-4359-B8EA-9B54ED5A54E3Q40157681-5B0DCAD9-A441-45E5-94C1-31234365B3A8Q40163769-61456A45-485A-4BD4-B0ED-350E69389CEE
P2860
Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1984
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Two physically and serological ...... s and their phenotype variants
@en
Two physically and serological ...... and their phenotype variants.
@nl
type
label
Two physically and serological ...... s and their phenotype variants
@en
Two physically and serological ...... and their phenotype variants.
@nl
prefLabel
Two physically and serological ...... s and their phenotype variants
@en
Two physically and serological ...... and their phenotype variants.
@nl
P2860
P1476
Two physically and serological ...... s and their phenotype variants
@en
P2093
Peppler MS
P2860
P304
P407
P577
1984-01-01T00:00:00Z